Back to All Articles
You must be logged in to create a new articleBrowse articles with tag: Pharmaceutical Companies
Patent litigation serves as a key battleground for protecting innovation, safeguarding intellectual property rights, and shaping industry dynamics. In late... Read More
Featured
All Articles
Patexia Insight 157: Most Active Companies in Biosimilar Litigation (BPCIA Act)
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More
Patexia Insight 152: Best Performing Brand and Generic Pharmas of 2022 (ANDA)
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the... Read More
Patexia Insight 151: ANDA Litigators Who Moved in the Last 12 Months
In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by... Read More
Mikele Bicolli
Jul 27, 2022
In early 1983, Bolar Pharmaceutical Inc. wanted to bring a generic version of the Dalmane drug, a sleeping pill, to... Read More
Mikele Bicolli
Jun 24, 2022
Last week, a bipartisan group of six U.S. senators sent a letter to USPTO asking to take measures in order... Read More